Question 1

What is the catalog number for Dabrafenib (GSK2118436), B-Raf mutant inhibitor?

Accepted Answer

The catalog number for Dabrafenib (GSK2118436), B-Raf mutant inhibitor is TBI1569-25MG.

Question 2

What sizes are available for Dabrafenib (GSK2118436), B-Raf mutant inhibitor?

Accepted Answer

Dabrafenib (GSK2118436), B-Raf mutant inhibitor is available in the following size(s): 25 mg.

Question 3

Is Dabrafenib (GSK2118436), B-Raf mutant inhibitor in stock?

Accepted Answer

Dabrafenib (GSK2118436), B-Raf mutant inhibitor is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 5

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 6

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Dabrafenib (GSK2118436), B-Raf mutant inhibitor

Product Specifications

Bioactivity

Shipping Conditions

Frequently Asked Questions

Explore Other Products

GP2 (Glycoprotein 2) / ZAP75 (GP2/2569R), Biotin conjugate, 0.1mg/mL

Calretinin / Calbindin 2 (Mesothelioma Marker) (CALB2/2685), CF640R conjugate, 0.1mg/mL

CD45RA (158-4D3), CF640R conjugate, 0.1mg/mL

CD63 (LAMP3/968), CF555 conjugate, 0.1mg/mL

CD74 (BU45), 1mg/mL

P63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), CF568 conjugate, 0.1mg/mL